Montazer SM, Asadi A, Taghipour A, Rajabi A, et al. Impact of HIF-prolyl hydroxylase inhibitors on VEGF expression and vascular adverse events in chronic kidney disease: a meta-analysis of 34 randomized controlled trials. J Nephrol 2026 Jul 23:aajag065. doi: 10.1093.
PMID: 42488997